{"id":"https://openalex.org/W2129763580","doi":"https://doi.org/10.1158/1535-7163.mct-11-0480","title":"Therapeutic Potential of AZD1480 for the Treatment of Human Glioblastoma","display_name":"Therapeutic Potential of AZD1480 for the Treatment of Human Glioblastoma","alternate_titles":[],"publication_year":2011,"publication_date":"2011-12-01","ids":{"openalex":"https://openalex.org/W2129763580","doi":"https://doi.org/10.1158/1535-7163.mct-11-0480","mag":"2129763580","pmid":"https://pubmed.ncbi.nlm.nih.gov/22027691","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3237864"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-11-0480","doi":"https://doi.org/10.1158/1535-7163.mct-11-0480","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-11-0480","pdf_url":"https://aacrjournals.org/mct/article-pdf/10/12/2384/2319147/2384.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2129763580"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/mct/article-pdf/10/12/2384/2319147/2384.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018953215","display_name":"Braden C. McFarland","orcid":"https://orcid.org/0000-0002-7517-9688","observed_orcids":["https://orcid.org/0000-0002-7517-9688"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Braden C. McFarland","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Cell Biology and 2Surgery, University of Alabama at Birmingham, Birmingham, Alabama; and 3Cancer Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts","Authors' Affiliations: Departments of Cell Biology and Surgery, University of Alabama at Birmingham, Birmingham, Alabama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Cell Biology and 2Surgery, University of Alabama at Birmingham, Birmingham, Alabama; and 3Cancer Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts","institution_ids":["https://openalex.org/I32389192"]},{"raw_affiliation_string":"Authors' Affiliations: Departments of Cell Biology and Surgery, University of Alabama at Birmingham, Birmingham, Alabama","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079086272","display_name":"Jingyuan Ma","orcid":"https://orcid.org/0000-0003-2252-5177","observed_orcids":["https://orcid.org/0000-0003-2252-5177"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jing-Yuan Ma","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Cell Biology and 2Surgery, University of Alabama at Birmingham, Birmingham, Alabama; and 3Cancer Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts","Authors' Affiliations: Departments of Cell Biology and Surgery, University of Alabama at Birmingham, Birmingham, Alabama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Cell Biology and 2Surgery, University of Alabama at Birmingham, Birmingham, Alabama; and 3Cancer Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts","institution_ids":["https://openalex.org/I32389192"]},{"raw_affiliation_string":"Authors' Affiliations: Departments of Cell Biology and Surgery, University of Alabama at Birmingham, Birmingham, Alabama","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031842530","display_name":"Catherine P. Langford","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Catherine P. Langford","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Cell Biology and 2Surgery, University of Alabama at Birmingham, Birmingham, Alabama; and 3Cancer Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts","Authors' Affiliations: Departments of Cell Biology and Surgery, University of Alabama at Birmingham, Birmingham, Alabama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Cell Biology and 2Surgery, University of Alabama at Birmingham, Birmingham, Alabama; and 3Cancer Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts","institution_ids":["https://openalex.org/I32389192"]},{"raw_affiliation_string":"Authors' Affiliations: Departments of Cell Biology and Surgery, University of Alabama at Birmingham, Birmingham, Alabama","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014191604","display_name":"G. Yancey Gillespie","orcid":"https://orcid.org/0000-0001-6436-9542","observed_orcids":["https://orcid.org/0000-0001-6436-9542"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. Yancey Gillespie","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Cell Biology and 2Surgery, University of Alabama at Birmingham, Birmingham, Alabama; and 3Cancer Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts","Authors' Affiliations: Departments of Cell Biology and Surgery, University of Alabama at Birmingham, Birmingham, Alabama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Cell Biology and 2Surgery, University of Alabama at Birmingham, Birmingham, Alabama; and 3Cancer Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts","institution_ids":["https://openalex.org/I32389192"]},{"raw_affiliation_string":"Authors' Affiliations: Departments of Cell Biology and Surgery, University of Alabama at Birmingham, Birmingham, Alabama","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034488692","display_name":"Hao Yu","orcid":"https://orcid.org/0000-0002-8351-1206","observed_orcids":["https://orcid.org/0000-0002-8351-1206"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hao Yu","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Cell Biology and 2Surgery, University of Alabama at Birmingham, Birmingham, Alabama; and 3Cancer Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts","Authors' Affiliations: Departments of Cell Biology and Surgery, University of Alabama at Birmingham, Birmingham, Alabama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Cell Biology and 2Surgery, University of Alabama at Birmingham, Birmingham, Alabama; and 3Cancer Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts","institution_ids":["https://openalex.org/I32389192"]},{"raw_affiliation_string":"Authors' Affiliations: Departments of Cell Biology and Surgery, University of Alabama at Birmingham, Birmingham, Alabama","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101951612","display_name":"Ying Zheng","orcid":"https://orcid.org/0000-0002-8852-5738","observed_orcids":["https://orcid.org/0000-0002-8852-5738","https://orcid.org/0000-0002-2433-5484"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ying Zheng","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Cell Biology and 2Surgery, University of Alabama at Birmingham, Birmingham, Alabama; and 3Cancer Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts","Authors' Affiliations: Departments of Cell Biology and Surgery, University of Alabama at Birmingham, Birmingham, Alabama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Cell Biology and 2Surgery, University of Alabama at Birmingham, Birmingham, Alabama; and 3Cancer Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts","institution_ids":["https://openalex.org/I32389192"]},{"raw_affiliation_string":"Authors' Affiliations: Departments of Cell Biology and Surgery, University of Alabama at Birmingham, Birmingham, Alabama","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018808867","display_name":"Susan E. Nozell","orcid":"https://orcid.org/0000-0003-2960-4484","observed_orcids":["https://orcid.org/0000-0003-2960-4484"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Susan E. Nozell","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Cell Biology and 2Surgery, University of Alabama at Birmingham, Birmingham, Alabama; and 3Cancer Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts","Authors' Affiliations: Departments of Cell Biology and Surgery, University of Alabama at Birmingham, Birmingham, Alabama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Cell Biology and 2Surgery, University of Alabama at Birmingham, Birmingham, Alabama; and 3Cancer Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts","institution_ids":["https://openalex.org/I32389192"]},{"raw_affiliation_string":"Authors' Affiliations: Departments of Cell Biology and Surgery, University of Alabama at Birmingham, Birmingham, Alabama","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042406680","display_name":"Dennis Huszar","orcid":"https://orcid.org/0000-0001-7742-7940","observed_orcids":["https://orcid.org/0000-0001-7742-7940"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dennis Huszar","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Cell Biology and 2Surgery, University of Alabama at Birmingham, Birmingham, Alabama; and 3Cancer Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts","Authors' Affiliations: Departments of Cell Biology and Surgery, University of Alabama at Birmingham, Birmingham, Alabama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Cell Biology and 2Surgery, University of Alabama at Birmingham, Birmingham, Alabama; and 3Cancer Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts","institution_ids":["https://openalex.org/I32389192"]},{"raw_affiliation_string":"Authors' Affiliations: Departments of Cell Biology and Surgery, University of Alabama at Birmingham, Birmingham, Alabama","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032782967","display_name":"Etty N. Benveniste","orcid":"https://orcid.org/0000-0003-4120-5750","observed_orcids":["https://orcid.org/0000-0003-4120-5750"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Etty N. Benveniste","raw_affiliation_strings":["Authors' Affiliations: Departments of 1Cell Biology and 2Surgery, University of Alabama at Birmingham, Birmingham, Alabama; and 3Cancer Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts","Authors' Affiliations: Departments of Cell Biology and Surgery, University of Alabama at Birmingham, Birmingham, Alabama"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of 1Cell Biology and 2Surgery, University of Alabama at Birmingham, Birmingham, Alabama; and 3Cancer Bioscience, AstraZeneca R&D Boston, Waltham, Massachusetts","institution_ids":["https://openalex.org/I32389192"]},{"raw_affiliation_string":"Authors' Affiliations: Departments of Cell Biology and Surgery, University of Alabama at Birmingham, Birmingham, Alabama","institution_ids":["https://openalex.org/I32389192"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5018953215"],"corresponding_institution_ids":["https://openalex.org/I32389192"],"apc_list":null,"apc_paid":null,"fwci":5.7359,"has_fulltext":true,"cited_by_count":91,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.97032928,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"10","issue":"12","first_page":"2384","last_page":"2393"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.7103999853134155,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.7103999853134155,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.2849000096321106,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/azd1480","display_name":"AZD1480","score":0.9900000095367432},{"id":"https://openalex.org/keywords/jak1-inhibitor","display_name":"JAK1 inhibitor","score":0.5680000185966492},{"id":"https://openalex.org/keywords/jak2-inhibitors","display_name":"JAK2 inhibitors","score":0.9869999885559082},{"id":"https://openalex.org/keywords/stat3-signaling","display_name":"STAT3 signaling","score":0.8600000143051147},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9449999928474426},{"id":"https://openalex.org/keywords/jak-stat-signaling","display_name":"JAK/STAT signaling","score":0.8730000257492065},{"id":"https://openalex.org/keywords/constitutive-stat3-activation","display_name":"constitutive STAT3 activation","score":0.7099999785423279},{"id":"https://openalex.org/keywords/glioma-xenografts","display_name":"glioma xenografts","score":0.7670000195503235},{"id":"https://openalex.org/keywords/glioma-stem-cells","display_name":"glioma stem cells","score":0.9430000185966492},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.75},{"id":"https://openalex.org/keywords/tumor-cell-proliferation","display_name":"tumor cell proliferation","score":0.8100000023841858},{"id":"https://openalex.org/keywords/intracranial-tumor-growth","display_name":"intracranial tumor growth","score":0.753000020980835}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.7364915013313293},{"id":"https://openalex.org/C171958077","wikidata":"https://www.wikidata.org/wiki/Q419333","display_name":"STAT protein","level":4,"score":0.6555957198143005},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5907621383666992},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.576349139213562},{"id":"https://openalex.org/C157333092","wikidata":"https://www.wikidata.org/wiki/Q902835","display_name":"JAK-STAT signaling pathway","level":4,"score":0.5498703122138977},{"id":"https://openalex.org/C2778277574","wikidata":"https://www.wikidata.org/wiki/Q665327","display_name":"stat","level":4,"score":0.5453339219093323},{"id":"https://openalex.org/C112392421","wikidata":"https://www.wikidata.org/wiki/Q903451","display_name":"Janus kinase","level":3,"score":0.4922145903110504},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.4750347435474396},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4691036641597748},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4597293436527252},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.41621720790863037},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3437125086784363},{"id":"https://openalex.org/C2778923194","wikidata":"https://www.wikidata.org/wiki/Q14912019","display_name":"STAT3","level":3,"score":0.25051793456077576},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2052316665649414},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.07090291380882263},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.05452510714530945},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D004789","descriptor_name":"Enzyme Activation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005909","descriptor_name":"Glioblastoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050796","descriptor_name":"STAT3 Transcription Factor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053614","descriptor_name":"Janus Kinase 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1158/1535-7163.mct-11-0480","doi":"https://doi.org/10.1158/1535-7163.mct-11-0480","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-11-0480","pdf_url":"https://aacrjournals.org/mct/article-pdf/10/12/2384/2319147/2384.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:22027691","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22027691","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:2512729","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3237864","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3237864","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3237864/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Mol Cancer Ther","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.mct-11-0480","doi":"https://doi.org/10.1158/1535-7163.mct-11-0480","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-11-0480","pdf_url":"https://aacrjournals.org/mct/article-pdf/10/12/2384/2319147/2384.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8560000061988831,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1461420553","display_name":"Characterizing the Role of NF-kB in Promoting Glioma Tumorigenicity","funder_award_id":"R01CA138517","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G1599491669","display_name":"TRADD as a Regulator of Cytokine Signaling in Glia","funder_award_id":"R01NS050665","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G2194436067","display_name":"Therapeutic Intervention of the JAK/STAT Pathway for Neuroinflammation","funder_award_id":"R01NS057563","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G3113243135","display_name":"Training Program in Rheumatic Diseases Research","funder_award_id":"T32AR007450","funder_id":"https://openalex.org/F4320337362","funder_display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"},{"id":"https://openalex.org/G4027850796","display_name":"CONTEMPORARY THERAPEUTICS FOR ANAPLASTIC GLIOMAS","funder_award_id":"P20CA151129","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8288740319","display_name":"Training Program in Brain Tumor Biology","funder_award_id":"T32NS048039","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G913463245","display_name":"Molecular Therapeutics for Anaplastic Gliomas","funder_award_id":"P50CA097247","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"},{"id":"https://openalex.org/F4320337362","display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","ror":"https://ror.org/006zn3t30"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2129763580.pdf","grobid_xml":"https://content.openalex.org/works/W2129763580.grobid-xml"},"referenced_works_count":49,"referenced_works":["https://openalex.org/W1487779062","https://openalex.org/W1947901393","https://openalex.org/W1968855063","https://openalex.org/W1988986134","https://openalex.org/W1989327734","https://openalex.org/W1989958716","https://openalex.org/W2001544973","https://openalex.org/W2003681585","https://openalex.org/W2011845911","https://openalex.org/W2017715430","https://openalex.org/W2024282024","https://openalex.org/W2029079922","https://openalex.org/W2030865745","https://openalex.org/W2036044314","https://openalex.org/W2039233803","https://openalex.org/W2041244673","https://openalex.org/W2044227662","https://openalex.org/W2048043668","https://openalex.org/W2049333880","https://openalex.org/W2059287377","https://openalex.org/W2062165914","https://openalex.org/W2067637255","https://openalex.org/W2071067115","https://openalex.org/W2076752985","https://openalex.org/W2080713919","https://openalex.org/W2096287682","https://openalex.org/W2099064703","https://openalex.org/W2099705390","https://openalex.org/W2109767323","https://openalex.org/W2110265246","https://openalex.org/W2113942802","https://openalex.org/W2122511443","https://openalex.org/W2124224257","https://openalex.org/W2128387672","https://openalex.org/W2132344640","https://openalex.org/W2133982451","https://openalex.org/W2134871530","https://openalex.org/W2136734008","https://openalex.org/W2137648328","https://openalex.org/W2139462220","https://openalex.org/W2140301591","https://openalex.org/W2144159648","https://openalex.org/W2151335185","https://openalex.org/W2158849161","https://openalex.org/W2161289668","https://openalex.org/W2164189319","https://openalex.org/W2167648407","https://openalex.org/W2167650288","https://openalex.org/W4253186968"],"related_works":["https://openalex.org/W2124556650","https://openalex.org/W2112547623","https://openalex.org/W2165174685","https://openalex.org/W4388107126","https://openalex.org/W2117222458","https://openalex.org/W2484156937","https://openalex.org/W2417213577","https://openalex.org/W2161333480","https://openalex.org/W2317171615"],"abstract_inverted_index":{"Aberrant":[0],"activation":[1,184],"of":[2,10,35,40,51,91,105,154,162,199,205,219,233],"the":[3,33,47,103,122,127,152,186,197,220,231],"Janus":[4],"kinase":[5],"(JAK)/signal":[6],"transducer":[7],"and":[8,42,57,67,71,77,81,89,126,138,159,164,176,202],"activator":[9],"transcription":[11],"(STAT)":[12],"pathway":[13,222],"has":[14],"been":[15],"implicated":[16],"in":[17,48,55,74,86,108,117,131,166,171,185,190,230],"glioblastoma":[18],"(GBM)":[19],"progression.":[20],"To":[21],"develop":[22],"a":[23,37,84],"therapeutic":[24],"strategy":[25],"to":[26,83],"inhibit":[27],"STAT-3":[28,72,139,165,183,213],"signaling,":[29],"we":[30,94],"have":[31],"evaluated":[32],"effects":[34],"AZD1480,":[36],"pharmacologic":[38,217],"inhibitor":[39],"JAK1":[41],"JAK2.":[43],"In":[44,133,193],"this":[45],"study,":[46],"vitro":[49],"efficacy":[50],"AZD1480":[52,62,156,181,195,224],"was":[53],"tested":[54],"human":[56,76,96,111],"murine":[58,78],"glioma":[59,79],"cell":[60,87,178,188],"lines.":[61],"treatment":[63,232],"effectively":[64],"blocks":[65],"constitutive":[66,158],"stimulus-induced":[68,160],"JAK1,":[69],"JAK2,":[70],"phosphorylation":[73,161],"both":[75,121],"cells,":[80],"leads":[82],"decrease":[85],"proliferation":[88],"induction":[90],"apoptosis.":[92],"Furthermore,":[93,180],"used":[95],"xenograft":[97,135,169],"GBM":[98,112,168,191,209,236],"samples":[99,113],"as":[100,115],"models":[101],"for":[102,228],"study":[104,229],"JAK/STAT-3":[106,221],"signaling":[107],"vivo,":[109,194],"because":[110],"propagated":[114],"xenografts":[116],"nude":[118],"mice":[119,206],"retain":[120],"hallmark":[123],"genetic":[124],"alterations":[125],"invasive":[128],"phenotype":[129],"seen":[130],"vivo.":[132],"these":[134,167],"tumors,":[136,147],"JAK2":[137,163],"are":[140],"constitutively":[141],"active,":[142],"but":[143],"levels":[144],"vary":[145],"among":[146],"which":[148],"is":[149],"consistent":[150],"with":[151,235],"heterogeneity":[153],"GBMs.":[155],"inhibits":[157,177,196],"tumors":[170,201,210],"vitro,":[172],"downstream":[173],"gene":[174],"expression,":[175],"proliferation.":[179],"suppresses":[182],"glioma-initiating":[187],"population":[189],"tumors.":[192,237],"growth":[198],"subcutaneous":[200],"increases":[203],"survival":[204],"bearing":[207],"intracranial":[208],"by":[211,223],"inhibiting":[212],"activity,":[214],"indicating":[215],"that":[216],"inhibition":[218],"should":[225],"be":[226],"considered":[227],"patients":[234]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2129763580","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":17},{"year":2013,"cited_by_count":17},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
